Company

HuidaGene Therapeutics

Biotechnology Research Shanghai, Shanghai Shi, Cn 34 employees

Employees: 34
Contacts: 2
Emails: 2

www.huidagene.com LinkedIn Crunchbase

HuidaGene Therapeutics Overview

Headquarters: Shanghai, Shanghai Shi, Cn
Website: www.huidagene.com
Industry: Biotechnology Research
Employees: 34
Founded: 2018
Funding: 3
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Gene editing CRISPR Gene Therapy Genome Medicine

About HuidaGene Therapeutics

HuidaGene Biotechnology Co., Ltd (辉大基因) is a global clinical-stage biotechnology company focusing on the discovering, engineering, and developing CRISPR-based gene-editing tools and gene therapies to rewrite the future of genomic medicine. Based in Shanghai and New Jersey, HuidaGene is committed to addressing patient's needs globally with various preclinical therapeutic programs covering ophthalmology, otology, myology, and neurology. Company's CRISPR-based therapeutics offer the potential to cure patients with life-threatening conditions by repairing the cause of their disease. We are committed to transform the future of genome-editing medicine.

HuidaGene Therapeutics Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage

HuidaGene Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Darren Wei	IT Director	Pudong, Shanghai, China	Email
Tj Cradick, Ph.d.	Chief Technology Officer (CTO) Crispr	Cambridge, Massachusetts, United States	Email
Fangxin Li	China Gm at Huidagene Therapeutics		View